Established colorectal carcinogenesis classifications, using a combination of KRAS and BRAF mutations with CIMP and MSI status, allow the identification of three to five distinct molecular sub-groups of CRC [36], [37]. This evidence concerns the gene KRAS and colorectal carcinoma.